Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.12. | INTEGRUM AB: Enhanced Commercial Focus Leads to Rebound in Stage One Surgeries in the US | 2 | Cision News | ||
29.11. | Integrum AB: Invitation to the Second Quarter 2024/25 Results Presentation | 1 | Cision News | ||
28.11. | INTEGRUM AB: Integrum Launches Service Initiative to Strengthen U.S. Market Growth | 1 | Cision News | ||
31.10. | INTEGRUM AB: Osseointegration for Amputees Makes its Education Forum Debut at OTA 2024 | 1 | Cision News | ||
17.10. | Integrum Energy Infra to raise funds via IPO - Check Details | 2 | ZEE Business | ||
17.10. | Integrum Energy Infra files draft papers to mobilise funds via IPO | 4 | Times of India | ||
07.10. | INTEGRUM AB: Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees | 3 | Cision News | ||
23.09. | Integrum ESG Raises £3.4M in Funding | 4 | FinSMEs | ||
INTEGRUM Aktie jetzt für 0€ handeln | |||||
20.09. | INTEGRUM AB: Join Us for an Investor Update Online with our Acting CEO Scott Flora | 2 | Cision News | ||
17.09. | INTEGRUM AB: Inger Rydin is appointed interim COO and takes office immediately | 1 | Cision News | ||
15.09. | Integrum AB: The board of Integrum appoints Scott Flora as acting CEO | 109 | GlobeNewswire (Europe) | Integrums CEO Rickard Brånemark has today agreed together with the board that he will leave the CEO role. The board announces that Scott Flora, board member since 2023, has been appointed acting CEO... ► Artikel lesen | |
06.09. | Integrum ESG and CSRHub enable fund managers to monitor both long-term trends and short-term movements in ESG ratings for companies, across a 10-year time series | 234 | PR Newswire | LONDON, Sept. 6, 2024 /PRNewswire/ -- Integrum ESG, the leading alternative ESG data provider, has today announced the launch of their Consensus ESG Ratings module.
Just as investors... ► Artikel lesen | |
29.08. | INTEGRUM AB: Focus on long-term growth creates setback in sales | 4 | Cision News | ||
26.08. | Integrum AB: Invitation to the First Quarter 2024/25 Results Presentation | 2 | Cision News | ||
18.06. | Onar, Inc.: Integrum Worldwide Announces Rebrand to ONAR at Cannes Lions | 273 | ACCESSWIRE | LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / Integrum Worldwide, the global marketing agency group, is thrilled to unveil its transformation into Onar (pronounced, "honor"). This rebrand reflects... ► Artikel lesen | |
15.06. | Im Test! Kingdom Hearts Integrum Masterpiece für Steam | 1 | JPGames | ||
29.02. | Integrum AB: A new record revenue quarter with 61% growth | 434 | PR Newswire | MÖLNDAL, Sweden, Feb. 29, 2024 /PRNewswire/ --
THIRD QUARTER 2023/24 (NOV - JAN)
Net sales amounts to 30.1 (18.7) MSEK, which is an increase of 61% compared with the corresponding period last... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 79,53 | +0,14 % | Medtronic declares $0.70 dividend | ||
INTUITIVE SURGICAL | 522,40 | +2,21 % | $1000 Invested In Intuitive Surgical 15 Years Ago Would Be Worth This Much Today | ||
STRATEC | 32,650 | +6,01 % | Stratec: Gegenreaktion verpufft? | Stratec ISIN: DE000STRA555 hat im Wochenverlauf 7,62 Prozent an Wert verloren und notiert zum Handelsende am Freitag bei 29,10 Euro auf Xetra. Mit diesem Kursverlust war der international tätige Labor-... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 47,730 | +0,55 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2024 | Regulatory News:
Eurofins (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation... ► Artikel lesen | |
VITA 34 | 4,340 | 0,00 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
HIMS & HERS HEALTH | 28,280 | -3,48 % | Ro partners with Eli Lilly to enhance obesity treatment access; Hims & Hers Health shares fall | ||
GERATHERM MEDICAL | 3,680 | +4,55 % | Geratherm Medical Aktie: Rückschläge hinnehmen müssen | ||
SYNLAB | 11,300 | +0,53 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
ALIGN TECHNOLOGY | 229,50 | +1,86 % | Align Technology, Inc.: Align Technology Has Received CE Mark in Europe for the Invisalign Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients | Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders. With Invisalign First aligners and Invisalign® Palatal... ► Artikel lesen | |
BOSTON SCIENTIFIC | 86,00 | 0,00 % | Boston Scientific To Buy Intera Oncology For Undisclosed Terms | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a privately held medical device company. Intera... ► Artikel lesen | |
PAUL HARTMANN | 215,00 | -0,46 % | Paul Hartmann-Aktie // Erhöhte Gewinnprognose | Eine der ersten Aktien, die wir bei Plusvisionen in diesem Jahr auf den Prüfstand stellten, war das Papier der Paul Hartmann AG. Damals verweisen wir vor allem auf Produktneuheiten, weshalb uns das... ► Artikel lesen | |
INMODE | 17,740 | +0,60 % | InMode Ltd.: InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the ... | YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
RESMED | 233,60 | +0,26 % | RESMED INC: NOTICE OF PROPOSED SALE OF SECURITIES | ||
INVITAE | 0,110 | 0,00 % | Invitae Aktie: Drastischer Kursverfall trotz Umsatzwachstum | Der Aktienkurs des Biotechnologieunternehmens Invitae ist in den letzten Tagen stark eingebrochen. Am 8. September fiel der Kurs um 25% auf 0,0003 USD, was einen besorgniserregenden Trend fortsetzt.... ► Artikel lesen | |
MCKESSON | 545,00 | -1,80 % | McKesson Corp: Personalchefin verkauft Aktien im Wert von 349.026 US-Dollar |